Guideline for Primary Antifungal Prophylaxis for Pediatric Patients with Cancer or Hematopoietic Stem Cell Transplant Recipients

A clinical practice guideline for pediatric patients with hematopoietic cancer or receiving stem cell transplants. The guideline examines antifungal prophylaxis to prevent invasive fungal infections, primarily through fluconazole. Outcomes of interest include lower rates of fungal related mortality and improved optimal pediatric dosing.